Reduce urinary urgency and frequency
- Trial ID
- NCT05814614
- Official Title
- Lower Urinary Tract Symptoms in Parkinson's Disease Effectiveness of Pelvic Floor Muscle Exercises and Electrical Stimulation, a Randomized Control Trial
- Goal
- Reduce urinary urgency and frequency
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Leiden University Medical Center
- Study Type
- INTERVENTIONAL
- Enrollment
- 150 participants
- Conditions
- Lower Urinary Tract Symptoms, Parkinson Disease
- Interventions
- pelvic physical therapy
Plain-Language Summary
The goal is to ease urgency, frequent daytime urination, and nighttime trips to the bathroom that many people with Parkinson's experience. The approach uses guided pelvic floor muscle exercises combined with mild electrical stimulation, the exercises strengthen the pelvic muscles and the stimulation helps calm overactive bladder nerves so the bladder can hold urine better, and because it is non-drug it does not interact with levodopa. They are enrolling adults 18 and older with Parkinson's who report lower urinary tract symptoms, have had stable Parkinson's medications for at least three months, and can read Dutch and attend pelvic physical therapy. People with other neurologic diseases, recent pelvic surgery or cancer treatment, current urinary infection or pregnancy, recent Botox, PTNS, or pelvic physiotherapy, or implanted devices like sacral stimulators, pacemakers, ICDs, or deep brain stimulators are excluded.
Locations
- Leiden Univesity Medical Center, Leiden, South Holland, Netherlands
Frequently Asked Questions
- What is this trial testing?
- This trial is studying pelvic physical therapy. The goal is to ease urgency, frequent daytime urination, and nighttime trips to the bathroom that many people with Parkinson's experience. The approach uses guided pelvic floor muscle exercises combined with mild electrical stimulation, the exercises strengthen the pelvic muscles and the stimulation helps calm overactive bladder nerves so the bladder can hold urine better, and because it is non-drug it does not interact with levodopa. They are enrolling adults 18 and older with Parkinson's who report lower urinary tract symptoms, have had stable Parkinson's medications for at least three months, and can read Dutch and attend pelvic physical therapy. People with other neurologic diseases, recent pelvic surgery or cancer treatment, current urinary infection or pregnancy, recent Botox, PTNS, or pelvic physiotherapy, or implanted devices like sacral stimulators, pacemakers, ICDs, or deep brain stimulators are excluded.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 5 months.